Advances in depression research: second special issue, 2020, with highlights on biological mechanisms, clinical features, co-morbidity, genetics, imaging, and treatment

Affiliations

¹ State University of New York, Upstate Medical University, Syracuse, NY, 13210, USA. juliolicinio@gmail.com.
² State University of New York, Upstate Medical University, Syracuse, NY, 13210, USA.

Editorial

Julio Licinio et al. Mol Psychiatry. 2020 Jul.

. 2020 Jul;25(7):1356-1360.

doi: 10.1038/s41380-020-0798-1.

¹ State University of New York, Upstate Medical University, Syracuse, NY, 13210, USA. juliolicinio@gmail.com.
² State University of New York, Upstate Medical University, Syracuse, NY, 13210, USA.

No abstract available

References

1. Chottekalapanda R, et al. AP-1 controls the p11-dependent antidepressant response. Mol Psychiatry. 2020. https://doi.org/10.1038/s41380-020-0767-8 .
1. Sagi Y, et al. Emergence of 5-HT5A signaling in parvalbumin neurons mediates delayed antidepressant action. Mol Psychiatry. 2019. https://doi.org/10.1038/s41380-019-0379-3 .
1. Oh SJ, et al. Hippocampal mossy cell involvement in behavioral and neurogenic responses to chronic antidepressant treatment. Mol Psychiatry. 2019. https://doi.org/10.1038/s41380-019-0384-6 .
1. Shuto T, et al. Obligatory roles of dopamine D1 receptors in the dentate gyrus in antidepressant actions of a selective serotonin reuptake inhibitor, fluoxetine. Mol Psychiatry. 2018. https://doi.org/10.1038/s41380-018-0316-x .
1. Schouten M, et al. Circadian glucocorticoid oscillations preserve a population of adult hippocampal neural stem cells in the aging brain. Mol Psychiatry. 2019. https://doi.org/10.1038/s41380-019-0440-2 .